Clinical examples back in the mix for future E/M documentation

Why This Topic Matters

Changes to E/M documentation affect how visits are documented, reviewed, and defended in audit settings. The article also highlights a related coverage-policy question that can influence drug reimbursement decisions under Medicare.

Article Sections

1. E/M documentation reform and clinical examples

   Discussion of proposed revisions to evaluation and management documentation and the role of clinical examples in the developing framework.

2. Audit concerns and implementation questions

   Coverage of concerns raised by auditors and CMS staff about how a future documentation system could be reviewed and applied.

3. Change sought on coverage of drugs not self-administered

   Summary of a separate Medicare coverage issue involving how drug coverage decisions may be considered and communicated.

4. History of E/M documentation guidelines

   A timeline of prior developments, stakeholder reactions, and policy milestones related to evaluation and management documentation guidance.